During a two-hour experimental chat with a therapist chatbot character, it “actively encouraged me to disregard my ...

Most Medicare enrollees will face premiums that are 10% higher next year, creating budget anxiety for millions of seniors.

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

The deals keeps coming. Merck this morning said it will acquire Cidara Therapeutics, the maker of an experimental flu therapy ...

Jenna Norton, a vocal critic of Trump administration actions at the NIH, was abruptly placed on administrative leave this ...

A strategic and financial recalibration on psychiatric drug development brings profound implications for investors, insurers, ...

A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...

Restrictions on gender-affirming care for minors consistently allow exceptions for minors with intersex traits, a new study ...

Republicans want to replace enhanced ACA tax credits with direct payments to individuals. Their think tank allies aren’t so ...

Merck is buying Cidara Therapeutics for $9.2B, picking up an experimental flu therapy as it looks to broaden its pipeline.

Merck agreed to buy Cidara Therapeutics, the maker of an experimental flu therapy, in a $9.2 billion deal, as the ...

The FDA approved a drug made by Kura Oncology to treat patients with a certain type of genetically altered leukemia.